학술논문

Addition of rituximab to chemotherapy reduced the rate of surgery for gastric-DLBCL without increasing early mortality
Document Type
Article
Source
In: Anticancer Research. (Anticancer Research, 2017, 37(2):813-818)
Subject
Language
English
ISSN
17917530
02507005